Cimeio Therapeutics company logo

Cimeio Therapeutics

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cimeio.com

Founded Year

2020

Stage

Series A | Alive

Total Raised

$50M

Last Raised

$50M | 2 mos ago

About Cimeio Therapeutics

Cimeio Therapeutics is a biotechnology company developing an approach to cell therapies. It was founded in 2020 and is based in Basel, Switzerland.

Cimeio Therapeutics Headquarter Location

Aeschenvorstadt 36

Basel, 4051,

Switzerland

+41 61 577 2316

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cimeio Therapeutics News

Basler startup receives 46 million Swiss francs for cell therapy

Apr 19, 2022

Cimeio Therapeutics has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup established by the Uni...

  • When was Cimeio Therapeutics founded?

    Cimeio Therapeutics was founded in 2020.

  • Where is Cimeio Therapeutics's headquarters?

    Cimeio Therapeutics's headquarters is located at Aeschenvorstadt 36, Basel.

  • What is Cimeio Therapeutics's latest funding round?

    Cimeio Therapeutics's latest funding round is Series A.

  • How much did Cimeio Therapeutics raise?

    Cimeio Therapeutics raised a total of $50M.

  • Who are the investors of Cimeio Therapeutics?

    Investors of Cimeio Therapeutics include Versant Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.